Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China · Delayed Price · Currency is CNY 12.55
+0.66 (5.55%)
Aug 20, 2026, 3:00 PM CST
SHA:688553 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,828 | 7,498 | 6,439 | 6,409 | 6,604 | 14,246 | |
Market Cap Growth | -28.15% | 16.45% | 0.46% | -2.95% | -53.64% | - |
Enterprise Value | 5,745 | 5,380 | 4,395 | 4,006 | 3,901 | 13,644 |
Last Close Price | 12.55 | 11.87 | 9.88 | 9.68 | 9.83 | 21.01 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 347.39 | - | 19.79 | 45.85 | 26.52 | 31.95 |
PS Ratio | 7.61 | 7.51 | 5.88 | 6.91 | 4.42 | 7.81 |
PB Ratio | 2.08 | 2.00 | 1.62 | 1.70 | 1.78 | 4.00 |
P/TBV Ratio | 2.10 | 2.03 | 1.64 | 1.73 | 1.81 | 4.08 |
P/FCF Ratio | 279.75 | - | 56.10 | - | - | 1103.46 |
P/OCF Ratio | 72.40 | 82.84 | 26.50 | 95.75 | 34.03 | 31.92 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.59 | 5.39 | 4.02 | 4.32 | 2.61 | 7.48 |
EV/EBITDA Ratio | 46.86 | 50.05 | 31.78 | 61.45 | 21.16 | 29.10 |
EV/EBIT Ratio | 195.34 | 287.17 | 72.08 | 627.16 | 28.54 | 31.47 |
EV/FCF Ratio | 205.32 | - | 38.30 | - | - | 1056.83 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.18 | 0.17 | 0.15 | 0.11 | 0.02 | 0.01 |
Debt / EBITDA Ratio | 5.63 | 5.72 | 4.19 | 6.14 | 0.29 | 0.04 |
Debt / FCF Ratio | 24.68 | - | 5.15 | - | - | 1.55 |
Net Debt / Equity Ratio | -0.55 | -0.55 | -0.61 | -0.57 | -0.68 | -0.83 |
Net Debt / EBITDA Ratio | -17.11 | -19.14 | -17.54 | -32.82 | -13.70 | -6.29 |
Net Debt / FCF Ratio | -74.03 | 139.40 | -21.14 | 9.31 | 9.44 | -228.35 |
Asset Turnover | 0.20 | 0.20 | 0.22 | 0.21 | 0.36 | 0.68 |
Inventory Turnover | 0.93 | 0.99 | 1.20 | 0.83 | 1.05 | 1.17 |
Quick Ratio | 2.25 | 2.44 | 2.78 | 3.07 | 5.07 | 6.11 |
Current Ratio | 2.61 | 2.69 | 2.94 | 3.26 | 5.46 | 6.56 |
Return on Equity (ROE) | 0.46% | -0.79% | 8.15% | 3.72% | 6.84% | 20.69% |
Return on Assets (ROA) | 0.36% | 0.23% | 0.77% | 0.09% | 2.03% | 10.14% |
Return on Invested Capital (ROIC) | 1.74% | 1.16% | 3.46% | 0.45% | 15.17% | 106.13% |
Return on Capital Employed (ROCE) | 0.80% | 0.50% | 1.50% | 0.20% | 3.60% | 11.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.29% | -0.33% | 5.05% | 2.18% | 3.77% | 3.13% |
FCF Yield | 0.36% | -0.20% | 1.78% | -3.58% | -4.05% | 0.09% |
Dividend Yield | 1.14% | 1.14% | 3.17% | 1.49% | 1.62% | 0.68% |
Payout Ratio | 885.13% | - | 30.16% | 70.19% | 36.21% | 0.15% |
Buyback Yield / Dilution | 1.19% | 1.45% | 0.23% | -0.35% | -13.60% | -2.81% |
Total Shareholder Return | 2.27% | 2.59% | 3.40% | 1.14% | -11.98% | -2.13% |